DOI QR코드

DOI QR Code

Comparative Modeling of Human P-gp NBD2 and Docking and Binding Mode Analysis of 8-Geranyl Chrysin as a P-gp Modulator

  • Gadhe, Changdev G. (Department of Pharmacoinformatics, National Institute of Pharmaceutical Education and Research)
  • Received : 2012.02.05
  • Accepted : 2012.03.27
  • Published : 2012.03.30

Abstract

The resistance of tumour cells against cytotoxic drug is significant limitation in successful chemotherapeutic treatment of cancer. To date, no crystal structure is available for human P-gp. We developed homology model for human P-gp NBD2 by using coordinates of transporter associated protein (TAP1). Docking study was performed for 8-geranyl-chrysin (Flavonoids) inhibitor in the NBD2 model. Ligand-protein interactions were determined which indicates that the 8-geranyl chrysin shares two overlapping sites in the cytosolic domains of P-gp, the ATP site and a hydrophobic steroid-binding site.

Keywords

References

  1. S. V. Ambudkar, S. Dey, C. A. Hrycyna, M. Ramachandra, I. Pastan and M. M. Gottesman, "title" Annu. Rev. Pharmacol. Toxicol. Vol. 39, pp. 361. 1999. https://doi.org/10.1146/annurev.pharmtox.39.1.361
  2. A. Scalbert and G. Williamson, "Dietary intake and bioavailability of polyphenols", J. Nutr. Vol. 130, pp. 2073S-2085S, 2000.
  3. P. C. H. Hollman and M. B. Katan, "Dietary flavonoids: Intake, health effects and bioavailability", Food Chem. Toxicol., Vol. 37, pp. 937-942, 1999. https://doi.org/10.1016/S0278-6915(99)00079-4
  4. J. Hunter and B. H. Hirst, "Intestinal secretion of drugs. The role of P-glycoprotein and related drug efflux systems in limiting oral drug absorption", Adv. Drug. Deliv. Rev., Vol. 25, pp. 129-157, 1997. https://doi.org/10.1016/S0169-409X(97)00497-3
  5. J. Van Asperen, O. Van Tellingen and J. Beijnen, "The pharmacological role of P-glycoprotein in the intestinal epithelium", Pharmacol. Res., Vol. 37, pp. 429-435, 1998. https://doi.org/10.1006/phrs.1998.0326
  6. A. Di Pietro, G. Conseil, J. M. Perez-Victoria, G. Dayan, H. Baubichon-Cortay, D. Trompier, E. Steinfels, J. M. Jault, H. de Wet, M. Maitrejean, G. Comte, A. Boumendjel, A. M. Mariotte, C. Dumontet, D. McIntosh, A. Goffeau, S. Castanys, F. Gamarro and D. Barron, "Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters", Cell Mol. Life Sci., Vol. 59, pp. 307-322, 2002. https://doi.org/10.1007/s00018-002-8424-8
  7. A. Boumendjel, A. Di Pietro, C. Dumontet and D. Barron, "Recent advances in the discovery of flavonoids and analogs with high-affinity binding to Pglycoprotein responsible for cancer cell multidrug resistance", Med. Res. Rev., Vol. 22, pp. 512-529, 2002. https://doi.org/10.1002/med.10015
  8. N. Eswar, B. John, N. Mirkovic, A. Fiser, V. A. Ilyin, U. Pieper, A. C. Stuart, M. A. Marti-Renom, M. S. Madhusudhan, B. Yerkovich and A. Sali, "Tools for comparative protein structure modeling and analysis", Nucleic Acids Res., Vol. 31, pp. 3375-3380, 2003. https://doi.org/10.1093/nar/gkg543
  9. S. H. R. SYBYL8.1; Tripos Inc., St. Louis, MO 63144 USA.
  10. J. Ruppert, W. Welch and A. N. Jain, "Automatic identification and representation of protein binding sites for molecular docking", Protein Sci., Vol. 6, pp. 524-533, 1997.
  11. S. Mares-SA'mano, R. Badhan and J. Penny, "Identification of putative steroid-binding sites in human ABCB1 and ABCG2", Eur. J. Med. Chem., Vol. 44, pp. 3601-3611, 2009. https://doi.org/10.1016/j.ejmech.2009.02.027

Cited by

  1. Molecular Docking Study of Novel Anti-Hepatitis B Virus Agents Isolated from Talaromyces Species vol.9, pp.1, 2016, https://doi.org/10.13160/ricns.2016.9.1.23
  2. Molecular Docking Study of Anti-diabetic Xanthones from Garcinia Xanthochymus vol.10, pp.3, 2017, https://doi.org/10.13160/ricns.2017.10.3.137
  3. Quantitative Structure–Activity Relationships for the Flavonoid-Mediated Inhibition of P-Glycoprotein in KB/MDR1 Cells vol.24, pp.9, 2012, https://doi.org/10.3390/molecules24091661